PALO ALTO, Calif., July 3 CA-Cell-Biosciences
PALO ALTO, Calif., July 3 /PRNewswire/ -- Cell Biosciences, Inc., a
provider of ultrasensitive protein detection and characterization systems to
life science researchers, today announced three key management team additions.
Jason Novi was named Chief Financial Officer, with responsibility for the
finance, manufacturing and administrative functions. Prior to joining Cell
Biosciences, Mr. Novi was the Vice President, Finance at Nektar Therapeutics.
He served as Director of Finance at Molecular Devices Corporation from 2000 to
2007, where he was responsible for all worldwide accounting, finance and
treasury functions, and played a key role in the execution and integration of
its corporate development activities.
Robert Gavin was named Vice President, Engineering. Mr. Gavin brings
nearly 20 years of experience to the Cell Biosciences development team. Most
recently, he served as Director of Engineering at MDS Analytical Technologies
(previously Molecular Devices), where he directed multidisciplinary teams of
mechanical, electrical, firmware, and systems engineers. Mr. Gavin has a
strong record of creating highly-successful laboratory systems, including
industry-leading optical plate readers and high throughput screening
platforms.
Also announced was the appointment of Wilhelm Lachnit, Ph.D. as Vice
President, Research and Development. Dr. Lachnit has two decades of experience
in pharma/biotech and life sciences. Most recently, he held both scientific
and commercial leadership positions at Molecular Devices, where he played a
central role in the development and launch of the IonWorks(TM) product line.
Previously, he pioneered the early adoption of automated cell-based assays at
Roche and Syntex (acquired by Roche). Dr. Lachnit holds a Ph.D. in
Pharmacology-Toxicology from the University of California, Davis.
"I am extremely pleased to announce these additions to the Cell
Biosciences leadership team," said Tim Harkness, President and Chief Executive
Officer. "These individuals have all been key contributors at successful life
science companies. I am confident that they will provide exceptionally strong
leadership as we develop our portfolio of ultrasensitive nano-proteomics
products."
About Cell Biosciences
Cell Biosciences is a private life sciences company focused on
nano-proteomics. We are developing instrumentation systems to enable the
detection and characterization of specific proteins in extremely small
biological samples. Our company's lead product, the Firefly 3000, is a
capillary-based nanofluidic immunoassay platform designed for ultrasensitive
detection and characterization of proteins. Cell Biosciences is located in
Palo Alto, CA. http://www.cellbiosciences.com
SOURCE Cell Biosciences, Inc.
